Citius Pharmaceuticals, Inc.CTXRNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank93
3Y CAGR-4.9%
5Y CAGR+10.8%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-4.9%/yr
vs +33.0%/yr prior
5Y CAGR
+10.8%/yr
Recent deceleration
Acceleration
-37.9pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
2 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$18.87M+1.8%
2025$18.53M+1.6%
2024$18.25M-16.7%
2023$21.91M+39.9%
2022$15.66M+38.7%
2021$11.29M+26.9%
2020$8.90M+27.1%
2019$7.00M-3.1%
2018$7.23M+2.5%
2017$7.05M-